Enjoei S.A. (BVMF:ENJU3)

Akoya Biosciences Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	196.76	198.8	261.69	309.1	382.54	486.71
Cash & Short-Term Investments	196.76	198.8	261.69	309.1	382.54	486.71
Cash Growth	-14.26%	-24.03%	-15.34%	-19.20%	-21.40%	15579.99%
Accounts Receivable	22.42	23.79	20.33	20.77	16	-
Other Receivables	0.25	0.31	0.06	15.55	7.69	3.38
Receivables	22.67	24.1	20.39	36.32	23.69	3.38
Prepaid Expenses	2.99	3.44	3.1	3.57	2.4	-
Other Current Assets	14.16	11.47	11.31	8.03	10.07	16.57
Total Current Assets	236.59	237.81	296.49	357.01	418.71	506.65
Property, Plant & Equipment	21.2	22.02	7.07	7.93	10.58	4.34
Long-Term Investments	48.79	46.87	-	-	-	-
Goodwill	9.53	9.53	9.53	-	-	-
Other Intangible Assets	105.22	105.95	99.44	65.42	42.57	17.74
Other Long-Term Assets	-	-	0.35	0.34	0.44	0.33
Total Assets	421.33	422.17	412.86	430.7	472.3	529.07
Accounts Payable	30.36	24.83	23.95	15.72	20.07	12.46
Accrued Expenses	22.11	20.57	20.16	13.45	9.52	4.86
Current Portion of Leases	2.9	2.65	2.1	1.66	2.15	0.73
Current Income Taxes Payable	0.01	0.02	0.04	0.12	-	0.08
Current Unearned Revenue	7.49	7.19	5.93	5.44	2.6	-
Other Current Liabilities	11.04	12.81	8.76	6.55	5.09	10.25
Total Current Liabilities	73.91	68.07	60.95	42.93	39.42	28.37
Long-Term Leases	7.89	8.41	1.84	3.53	5.61	1.19
Long-Term Deferred Tax Liabilities	5.18	5.36	6.08	-	-	-
Other Long-Term Liabilities	20.41	19.88	4.16	3.39	2.71	2.37
Total Liabilities	107.38	101.72	73.03	49.85	47.73	31.92
Common Stock	635.66	635.66	634.4	633.13	631.87	630.6
Retained Earnings	-374.7	-367.98	-344.04	-291.07	-224.56	-105.77
Comprehensive Income & Other	52.99	52.77	49.48	38.79	17.25	-27.69
Shareholders' Equity	313.95	320.45	339.84	380.85	424.56	497.14
Total Liabilities & Equity	421.33	422.17	412.86	430.7	472.3	529.07
Total Debt	10.78	11.06	3.95	5.19	7.75	1.92
Net Cash (Debt)	185.98	187.74	257.75	303.91	374.79	484.79
Net Cash Growth	-15.29%	-27.16%	-15.19%	-18.91%	-22.69%	-
Net Cash Per Share	0.91	0.92	1.28	1.53	1.90	8.44
Filing Date Shares Outstanding	205.02	205.02	202.63	200.24	197.86	195.47
Total Common Shares Outstanding	205.02	205.02	202.63	200.24	197.86	195.47
Working Capital	162.68	169.74	235.54	314.08	379.29	478.28
Book Value Per Share	1.53	1.56	1.68	1.90	2.15	2.54
Tangible Book Value	199.2	204.98	230.87	315.43	381.99	479.41
Tangible Book Value Per Share	0.97	1.00	1.14	1.58	1.93	2.45
Machinery	8.76	8.46	6.62	4.56	-	2
Construction In Progress	-	-	0.23	0.21	-	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.